TrialGerontology2020

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.

Yayquier Díaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.